All-treatment array of hepatocellular carcinoma from initial diagnosis to death: observation of cumulative treatments
Author:
Funder
National Cancer Center
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
http://link.springer.com/article/10.1007/s00432-017-2480-9/fulltext.html
Reference26 articles.
1. Korean Liver Cancer Study Group (KLCSG), National Cancer Center, Korea (NCC) (2015) 2014 KLCSG-NCC Korea practice guideline for the management of hepatocellular carcinoma. Gut liver 9:267–317. doi: 10.5009/gnl14460
2. Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update Hepatology 53:1020–1022. doi: 10.1002/hep.24199
3. Bruix J et al (2017) Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 389:56–66. doi: 10.1016/S0140-6736(16)32453-9
4. Chen CL, Kabiling CS, Concejero AM (2013) Why does living donor liver transplantation flourish in Asia? Nat Rev Gastroenterol Hepatol 10:746–751. doi: 10.1038/nrgastro.2013.194
5. Cheng SJ, Freeman RB Jr, Wong JB (2002) Predicting the probability of progression-free survival in patients with small hepatocellular carcinoma. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc 8:323–328. doi: 10.1053/jlts.2002.31749
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effect of lymphovascular invasion on survival and recurrence after liver transplantation in patients with hepatocellular carcinoma and its prognostic significance;2023-12-12
2. A retrospective study of transarterial chemoembolization (TACE) combined with lenvatinib compared with TACE monotherapy for BCLC B2 stage hepatocellular carcinoma;Oncology Letters;2023-10-10
3. Research progress of targeted therapy combined with immunotherapy for hepatocellular carcinoma;Frontiers in Oncology;2023-05-25
4. Identification of a novel circRNA–miRNA–mRNA regulatory axis in hepatocellular carcinoma based on bioinformatics analysis;Scientific Reports;2023-03-06
5. The role of miRNAs in liver diseases: Potential therapeutic and clinical applications;Pathology - Research and Practice;2023-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3